ANTWERP, Belgium and SAN FRANCISCO, June 1, 2016 /PRNewswire/ --
genae, a global Contract Research Organization (CRO) and service provider for the medical industries, announced today the expansion of its North American activities with the opening of offices in San Francisco. genae Americas was incorporated in 2011 and has since then opened offices in New York City and Cleveland, Ohio.
“San Francisco is strategically centered in one of the highest concentrations of medical innovation and leading research facilities on the West Coast”, said Philippe Kassab, President at genae Americas. “The expansion of genae from the East Coast to the West Coast supports our commitment to be closer to our industry partners and patient population, and to deliver high quality clinical research.”
As of May 2016, almost 40% of the world’s medical devices clinical trials were conducted in North-America, with a third of U.S. medical devices clinical trials on the West Coast.
About the genae group
genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. genae is a full service CRO and services provider for the medical industries and aims at improving health and quality of life by innovating and accelerating high quality research. The group’s Quality Management System has been tested rigorously and continues to pass regulatory and sponsor’s audits and inspections.
genae associates nv is a privately held company with principal offices in Antwerp, Belgium and is part of the genae group, the medical device CRO.
To learn more about genae, please visit http://www.genae.com.
Contact
genae associates nv
Bart Segers, CEO
+32-3-290-03-06
Justitiestraat 6B, 2018 Antwerp, Belgium
bart.segers@genae.com
genae Americas, Inc.
Philippe Kassab, President
+1-216-445-4535
10000 Cedar Avenue, Cleveland, OH 44106, USA
philippe.kassab@genae.com
